Ken Griffin Dbv Technologies S.A. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.75 - $0.95 $8,495 - $10,760	-11,327 Reduced 6.93%	152,019 $114,000
Q4 2023 Feb 14, 2024	BUY	$0.7 - $1.33 $54,502 - $103,555	77,861 Added 91.08%	163,346 $155,000
Q3 2023 Nov 14, 2023	BUY	$1.3 - $1.88 $73,559 - $106,377	56,584 Added 195.79%	85,485 $116,000
Q2 2023 Aug 14, 2023	BUY	$1.42 - $2.23 $41,039 - $64,449	28,901 New	28,901 $54,000
Q3 2021 Nov 15, 2021	SELL	$4.71 - $5.92 $7,300 - $9,176	-1,550 Reduced 7.1%	20,282 $99,000
Q2 2021 Aug 16, 2021	BUY	$5.32 - $6.53 $12,916 - $15,854	2,428 Added 12.51%	21,832 $119,000
Q1 2021 May 17, 2021	BUY	$2.75 - $6.57 $9,190 - $21,956	3,342 Added 20.81%	19,404 $103,000
Q4 2020 Feb 16, 2021	SELL	$1.38 - $3.01 $725,292 - $1.58 Million	-525,574 Reduced 97.03%	16,062 $42,000
Q2 2020 Aug 14, 2020	SELL	$3.74 - $6.28 $1.57 Million - $2.63 Million	-419,565 Reduced 43.65%	541,636 $2.38 Million
Q1 2020 May 15, 2020	BUY	$2.33 - $12.98 $1.89 Million - $10.5 Million	811,609 Added 542.55%	961,201 $3.77 Million
Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $713,171 - $1.18 Million	105,655 Added 240.47%	149,592 $1.6 Million
Q3 2019 Nov 14, 2019	SELL	$8.57 - $10.72 $450,773 - $563,861	-52,599 Reduced 54.49%	43,937 $377,000
Q2 2019 Aug 14, 2019	BUY	$7.58 - $10.0 $86,965 - $114,730	11,473 Added 13.49%	96,536 $794,000
Q1 2019 May 15, 2019	BUY	$5.81 - $9.37 $308,266 - $497,153	53,058 Added 165.78%	85,063 $0
Q4 2018 Feb 14, 2019	SELL	$5.75 - $21.85 $70,196 - $266,744	-12,208 Reduced 27.61%	32,005 $205,000
Q3 2018 Nov 13, 2018	SELL	$16.81 - $24.58 $7.24 Million - $10.6 Million	-430,535 Reduced 90.69%	44,213 $0
Q2 2018 Aug 10, 2018	SELL	$18.6 - $24.94 $6.35 Million - $8.52 Million	-341,619 Reduced 41.85%	474,748 $0
Q1 2018 May 11, 2018	BUY	$20.86 - $26.6 $11 Million - $14 Million	527,488 Added 182.6%	816,367 $18.8 Million
Q4 2017 Feb 09, 2018	BUY	$20.9 - $49.36 $2.2 Million - $5.19 Million	105,224 Added 57.29%	288,879 $7.11 Million
Q3 2017 Nov 09, 2017	BUY	$39.62 - $46.17 $7.28 Million - $8.48 Million	183,655	183,655 $7.79 Million

Others Institutions Holding DBVT

# of Institutions

Shares Held

3.2K

Call Options Held

Put Options Held

View Full List

About DBV Technologies S.A.

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $599M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

More about DBVT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account